Expression of survivin and p16INK4a/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of survivin and p16INK4a/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells

Published:2008-01 Issue: Volume:1188 Page:25-34
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Al-Khalaf Huda H.,Lach Boleslaw,Allam Ayman,Hassounah Maher,AlKhani Ahmed,Elkum Nasser,Alrokayan Salman A.,Aboussekhra Abdelilah

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference55 articles.

1. The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells;Al-Khalaf;J. Neurooncol.,2007

2. The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin;Al-Mohanna;Oncogene,2004

3. Survivin, versatile modulation of cell division and apoptosis in cancer;Altieri;Oncogene,2003

4. Validating survivin as a cancer therapeutic target;Altieri;Nat. Rev., Cancer,2003

5. The case for survivin as a regulator of microtubule dynamics and cell-death decisions;Altieri;Curr. Opin. Cell Biol.,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic influence of meningioma on cisplatin resistance: a Mendelian randomization analysis;International Journal of Clinical Pharmacy;2024-06-20

2. Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways;Molecular Therapy - Oncolytics;2021-03

3. Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations;Clinical and Translational Oncology;2020-04-06

4. CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML;EBioMedicine;2019-12

5. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers;Pathology & Oncology Research;2019-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3